Athersys Inc. [ATHX] fell -51.26% so far this year. What now?

Related

Athersys Inc. [NASDAQ: ATHX] price plunged by -7.00 percent to reach at -$0.07. The company report on November 30, 2021 that Report of Placebo-Controlled Clinical Trial Evaluating MultiStem® Cell Therapy for Acute Respiratory Distress Syndrome Published in Intensive Care Medicine.

Results show therapy was well-tolerated and support potential benefits in mortality, ventilator-free days, ICU-free days and quality of life outcomes.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Separately, data pooled from two independent studies provide further evidence of potential clinically meaningful benefit of MultiStem as a treatment for ARDS patients.

A sum of 2549304 shares traded at recent session while its average daily volume was at 1.78M shares. Athersys Inc. shares reached a high of $0.9283 and dropped to a low of $0.836 until finishing in the latest session at $0.85.

The one-year ATHX stock forecast points to a potential upside of 81.36. The average equity rating for ATHX stock is currently 1.70, trading closer to a bullish pattern in the stock market.

Guru’s Opinion on Athersys Inc. [ATHX]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATHX shares is $4.56 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATHX stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for Athersys Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on November 19, 2021. While these analysts kept the previous recommendation, BofA/Merrill raised their target price to Buy. The new note on the price target was released on June 25, 2020, representing the official price target for Athersys Inc. stock. Previously, the target price had yet another raise to $11, while Dawson James analysts kept a Buy rating on ATHX stock. On February 13, 2018, analysts decreased their price target for ATHX shares from 12 to 6.

The Average True Range (ATR) for Athersys Inc. is set at 0.08, with the Price to Sales ratio for ATHX stock in the period of the last 12 months amounting to 31.70. The Price to Book ratio for the last quarter was 6.56, with the Price to Cash per share for the same quarter was set at 0.22.

ATHX Stock Performance Analysis:

Athersys Inc. [ATHX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.33. With this latest performance, ATHX shares dropped by -16.38% in over the last four-week period, additionally sinking by -40.77% over the last 6 months – not to mention a drop of -53.14% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ATHX stock in for the last two-week period is set at 33.19, with the RSI for the last a single of trading hit 27.81, and the three-weeks RSI is set at 35.93 for Athersys Inc. [ATHX]. The present Moving Average for the last 50 days of trading for this stock 1.1184, while it was recorded at 0.9427 for the last single week of trading, and 1.4595 for the last 200 days.

Insight into Athersys Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Athersys Inc. [ATHX] shares currently have an operating margin of -5439.72. Athersys Inc.’s Net Margin is presently recorded at -5469.79.

Return on Total Capital for ATHX is now -283.24, given the latest momentum, and Return on Invested Capital for the company is -287.42. Return on Equity for this stock declined to -288.34, with Return on Assets sitting at -155.39. When it comes to the capital structure of this company, Athersys Inc. [ATHX] has a Total Debt to Total Equity ratio set at 2.16. Additionally, ATHX Total Debt to Total Capital is recorded at 2.12, with Total Debt to Total Assets ending up at 1.14. Long-Term Debt to Equity for the company is recorded at 0.56, with the Long-Term Debt to Total Capital now at 0.55.

Reflecting on the efficiency of the workforce at the company, Athersys Inc. [ATHX] managed to generate an average of -$812,010 per employee. Receivables Turnover for the company is 2.74 with a Total Asset Turnover recorded at a value of 0.03.Athersys Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.10 and a Current Ratio set at 2.10.

>> 7 Top Picks for the Post-Pandemic Economy <<

Athersys Inc. [ATHX] Insider Position Details

There are presently around $47 million, or 22.30% of ATHX stock, in the hands of institutional investors. The top three institutional holders of ATHX stocks are: BLACKROCK INC. with ownership of 14,500,588, which is approximately 1.565% of the company’s market cap and around 0.80% of the total institutional ownership; VANGUARD GROUP INC, holding 10,201,640 shares of the stock with an approximate value of $9.36 million in ATHX stocks shares; and STATE STREET CORP, currently with $3.47 million in ATHX stock with ownership of nearly 4.036% of the company’s market capitalization.

Positions in Athersys Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 59 institutional holders increased their position in Athersys Inc. [NASDAQ:ATHX] by around 3,124,212 shares. Additionally, 46 investors decreased positions by around 2,690,591 shares, while 49 investors held positions by with 45,288,518 shares. The mentioned changes placed institutional holdings at 51,103,321 shares, according to the latest SEC report filing. ATHX stock had 14 new institutional investments in for a total of 432,973 shares, while 13 institutional investors sold positions of 492,967 shares during the same period.